NCT06937099 · Interventional trial
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Overall registry status Recruiting
Phase 3
Conditions Crohn's Disease, Obesity or Overweight
Delaware Valley sites
- Thomas Jefferson University - Medicine/GI and Hepatology · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory